BlueLinx Holdings reports Q1 2026 results today facing its sharpest near-term price drop in months — and the question isn't whether short sellers are piling in, but whether the stock's freefall has already priced in the bad news.
The price action tells the starkest part of the story. BXC closed at $46.19 on Tuesday, down 5% on the day and 18% across the week — a move that dwarfs the sell-offs at closest peers Boise Cascade (-13% on the week) and SiteOne Landscape Supply (-15%). The stock has shed roughly 41% from the $79 range it held just three months ago. That decline has driven the EV/EBITDA multiple down nearly half a point over the past month to 7.7x, and the price-to-book has compressed to 0.63 — well below one.
Short positioning is not what's driving this move. Short interest is a modest 4.5% of free float, and it has actually declined nearly 7% over the past month. The borrow market is loose: availability is ample and cost to borrow is just 0.9%, roughly double what it was a month ago but still low in absolute terms. The ORTEX short score sits at 39.9 out of 100 — firmly in the middle of the range. This is not a crowded short thesis; it looks more like a stock under fundamental selling pressure.
The analyst community reflects that same unease, though coverage is thin. The most recent action — from Benchmark in late February — trimmed the target to $75, maintaining a Buy. DA Davidson last moved in November, cutting to $68 on a Neutral. Both of those targets are now well above the current price, and given the stock's subsequent collapse, the gap has widened materially. The mean target of $71.25 implies significant upside from here, but the direction of travel has been lower on every revision since at least mid-2025. The bull case centres on operational improvements — jobsite delivery investment, stronger customer engagement, and an earnings revision cycle that had turned positive. The bear case is blunter: EBITDA margins that hit their lowest Q2 level since 2018, a product mix skewed toward lower-margin structural products, and a second half that analysts already flagged as challenging before the tariff environment added further pressure.
The one prior earnings print with reaction data — February's Q4 release — saw the stock fall 3% on the day and nearly 9% over the following five days. The print today will test whether current pricing already reflects the margin deterioration that bears have been tracking, or whether Q1 results reveal a further deterioration that catches the remaining longs off-guard.
See the live data behind this article on ORTEX.
Open BXC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
